High-level expression of cyclooxygenase (COX)-2 is reported in 80 -90% of colorectal adenocarcinomas. Selective inhibition of COX-2 was shown to reduce colorectal tumorigenesis in different models of carcinogenesis and to prevent metastasis in xenograft tumor models, as well as to suppress in vitro
Effects of the Inhibition of Cyclooxygenase-2 on Human Esophageal Cancer Cells: Inhibition of Cell Proliferation and Induction of Apoptosis
β Scribed by Li Zhang; Jun Tu; Zhong-lin Yu; Yong-dong Wu; Cai-min Xu; Shu-tian Zhang
- Publisher
- Springer Netherlands
- Year
- 2009
- Tongue
- English
- Weight
- 187 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1219-4956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclita
## Abstract ExβFABP, an extracellular fatty acid binding lipocalin, is physiologically expressed by differentiating chicken chondrocytes and myoblasts. Its expression is enhanced after cell treatment with inflammatory stimuli and repressed by antiβinflammatory agents, behaving as an acute phase pro
## Abstract ## BACKGROUND Endometrial cancer is a common gynecologic malignancy among women. The molecular mechanisms involved in the progression of endometrial cancer are unclear, which has hampered the development of an effective treatment. Survivin, a newly identified member of the inhibitor of